ANGELALIGN

6699
76.3501.23% ( -0.950 )
Delay Closed: Nov 18, 16:08:04

News

  • How New Aligner Material At Angelalign Technology Stock Has Changed Its Investment Story

    Simplywall·
    - Angelalign Technology introduced SuperElastic MC-SE, a new medical grade polyamide aligner material featuring gentle force and strong recovery, aimed at supporting complex treatments. - The investment narrative relies on material innovation to justify premium pricing, though execution depends on regulatory approvals, manufacturing ramps, and clinic adoption. - Valuation and financial risks involve a rich P/E ratio of 43.4x, an uncovered 12.26% dividend, and significant insider selling.
  • AI Bets and Overseas Breakthroughs: Hong Kong Small-Caps Redefine Growth Trajectories

    Global Report·
    - Hong Kong small and mid-cap companies are actively pursuing strategic transformation through artificial intelligence integration, overseas market expansion, and business restructuring. - VPower Group issued new shares to introduce an AI strategic shareholder, while Ark Biotech achieved a 22.2 % revenue increase via its AI platform. - Traditional and manufacturing firms like Aobao and Lee & Man Paper adjusted internal operations to navigate industry pressures and market changes.
  • Angelalign drops 8%

    Market Movers·
    - Angelalign experienced an intraday drop of nearly 8%, reaching 74.60 HKD, with a 22.25% pullback from its 52-week high. - The Unified Patent Court in Paris ruled on October 16 that the company infringed upon Align Technology's patent, issuing a sales ban and recall across 17 European countries. - The company stated that the disputed feature has been replaced in Europe by Pressure Points technology and is currently appealing the ruling.
  • Weekly Recap | ANGELALIGN +1.95%, most brokers rate it buy

    Weekly Review·
    - Angelalign accumulated a 1.95% increase this week to close at 81.2 HKD, outperforming the Hang Seng Index by approximately 6.47 percentage points. - Among 10 covering institutions, 8 gave buy ratings, resulting in a consensus strong buy rating and a consensus target price of 107.002 HKD. - The next major financial release is scheduled for December 1, 2026, when the company will report its 2026 fiscal third-quarter results.
  • Wyrok paryskiego sądu w sprawie wycofanej technologii bez większych konsekwencji dla klientów Angelalign

    prnewswire·
    - Angelalign Technology Inc. announced that a Paris court ruling regarding its Torque Ridges technology will not impact its European offerings, as the company has already replaced it with the upgraded Pressure Points technology. - The court ruled that Torque Ridges infringed on a patent held by Align Technology Inc., prompting Angelalign to review the judgment while continuing to comply with legal requirements. - European orthodontists and international clients remain unaffected, retaining uninterrupted access to products, clinical support, and advanced treatment solutions.
  • La décision du tribunal de Paris concernant la suppression d'une fonctionnalité aura un impact minimal sur les clients d'Angelaign

    prnewswire·
    - Angelalign Technology Inc. announced that a Paris court ruling regarding its Torque Ridges feature will have minimal impact on its European operations and customer availability. - The company had already replaced Torque Ridges in Europe with an upgraded Pressure Points feature launched in September. - Markets including Spain, the UK, the Americas, and Asia remain unaffected, while Angelalign continues to review the court's decision involving Align Technology Inc.
  • Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers

    prnewswire·
    - Angelalign Technology Inc. announced that a Paris Unified Patent Court ruling regarding its discontinued Torque Ridges feature will have minimal impact on European customers. - The company has already replaced Torque Ridges with an upgraded Pressure Points feature in Europe as of September to maintain torque control. - While disagreeing with the decision that the feature infringed an Align Technology Inc. patent, Angelalign will comply with the ruling and continue offering uninterrupted support.